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ARTICLE
Human ESCRT-III polymers assemble on positively
curved membranes and induce helical membrane
tube formation
Aurélie Bertin 1,2,5✉, Nicola de Franceschi 1,2,3,5✉, Eugenio de la Mora 1,2, Sourav Maiti4,
Maryam Alqabandi1,2, Nolwen Miguet3, Aurélie di Cicco1,2, Wouter H. Roos4, Stéphanie Mangenot 1,2,
Winfried Weissenhorn 3✉ & Patricia Bassereau 1,2✉
Endosomal sorting complexes for transport-III (ESCRT-III) assemble in vivo onto membranes
with negative Gaussian curvature. How membrane shape influences ESCRT-III polymerization
and how ESCRT-III shapes membranes is yet unclear. Human core ESCRT-III proteins,
CHMP4B, CHMP2A, CHMP2B and CHMP3 are used to address this issue in vitro by com-
bining membrane nanotube pulling experiments, cryo-electron tomography and AFM. We
show that CHMP4B filaments preferentially bind to flat membranes or to tubes with positive
mean curvature. Both CHMP2B and CHMP2A/CHMP3 assemble on positively curved
membrane tubes. Combinations of CHMP4B/CHMP2B and CHMP4B/CHMP2A/CHMP3 are
recruited to the neck of pulled membrane tubes and reshape vesicles into helical “corkscrew-
like” membrane tubes. Sub-tomogram averaging reveals that the ESCRT-III filaments
assemble parallel and locally perpendicular to the tube axis, highlighting the mechanical
stresses imposed by ESCRT-III. Our results underline the versatile membrane remodeling
activity of ESCRT-III that may be a general feature required for cellular membrane remodeling
processes.
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The Endosomal Sorting Complex Required for Transport-III(ESCRT-III) is part of a conserved membrane remodelingmachine. ESCRT-III employs polymer formation to cata-
lyze inside-out membrane fission processes in a large variety of
cellular processes, including budding of endosomal vesicles and
enveloped viruses, cytokinesis, nuclear envelope reformation,
plasma membrane repair, exosome formation, neuron pruning,
dendritic spine maintenance, and preperoxisomal vesicle bio-
genesis1–8.
Yeast ESCRT-III comprises four subunits Vps20, Snf7, Vps2,
and Vps24, which polymerize in this order on endosomal
membranes9, and is dynamically regulated by the ATPase
VPSps410. The corresponding human homologues comprise
several isoforms named CHMP6 (Vps20), CHMP4A, B, C (Snf7),
CHMP2A, B (Vps2), and CHMP3 (Vps24) in addition to
CHMP1A, B, CHMP5, CHMP7, and CHMP8/IST15. ESCRT-III
proteins adopt an auto-inhibited conformation in the
cytosol11–13, which requires the release of the C-terminal auto-
inhibition14,15. This leads to the polymerization of loose
CHMP4 spirals16–18, helical CHMP2A-CHMP3 spirals12,19,20,
CHMP2A filaments21 and Vps24 (CHMP3) filaments22 in vitro.
In vivo, CHMP4 or CHMP2B over-expression leads to membrane
tube formation with CHMP4 and CHMP2B filaments inside the
tube23–25. Polymerization is guided by conformational changes
that stabilize the filaments via domain exchange, thereby gen-
erating basic surfaces for interaction with positively curved26 or
negatively curved membranes27 carrying a negative net
charge26,28,29. Although Snf7 (CHMP4) polymerizes on sup-
ported lipid bilayers18, preformed membrane curvature was
suggested to favor Snf7 (CHMP4) membrane interaction30,31.
Common to all ESCRT-mediated processes is the strict
requirement of VPS4 that not only recycles ESCRT-III32, but
actively remodels the polymers in vivo10,33 and in vitro34,35.
Furthermore, all ESCRT-catalyzed processes recruit CHMP4 and
CHMP2 isoform(s)2, indicating CHMP4 and CHMP2 are core
components for ESCRT-III function. Accordingly, HIV-1 bud-
ding requires only one CHMP4 and CHMP2 isoform for virus
release36, although the presence of CHMP3enhances budding
efficiency21. This thus suggests a minimal budding/membrane
fission machinery that requires CHMP4 and CHMP2 isoforms.
Consistent with this proposal, in vitro reconstitution experiments
implicated Snf7 (CHMP4), Vps24 (CHMP3) and Vps2
(CHMP2A) in Vps4-driven membrane tube release29, although
Did2 (CHMP1) and IST1 may as well participate in membrane
scission37. Based on the core fission machinery a number of
different models have been proposed to explain ESCRT-catalyzed
membrane fission5,7,38.
In vivo filament assembly has been imaged within bud necks of
viruses36,39,40. Similarly, ESCRT-III containing spirals have been
observed within the cytokinetic midbody41–43, and proposed to
be multi-stranded33,41. This thus suggests that ESCRT-III
assembles on membranes that exhibit a saddle-like shape with
negative Gaussian curvatures (See Supplementary Fig. 1 for a
definition of the different curvatures in this work).
Although the intrinsic curvature of the filaments and their
flexibility are likely important to shape membranes, the role of
ESCRT-III polymers and their preference for different or the
same membrane geometries is still unclear18,20,30,44.
Here we investigate how ESCRT-III polymerization shapes
membranes and how it influences their assembly on membranes.
To address these questions, we develop in vitro assays based on
the essential core of purified human ESCRT-III proteins
(CHMP4B, CHMP2A, CHMP2B, and CHMP3) and model
membrane systems. We use C-terminally truncated versions of
CHMP4B, CHMP2A, and CHMP2B to facilitate polymerization
as well as full-length CHMP3. We design confocal microscopy
experiments with membrane nanotubes of controlled geometries
pulled from Giant Unilamellar Vesicles (GUVs) to study the
effect of membrane mean curvature and topology on ESCRT-III
protein recruitment and polymerization at the macroscopic scale.
Furthermore, by using high-speed AFM (HS-AFM) and cryo-
electron microscopy (cryoEM), we obtain nanometer resolution
images showing the preferential membrane shape induced upon
ESCRT-III assembly on small liposomes and preformed tubes and
the corresponding organization of the protein filaments at their
surface.
Results
CHMP4B does not deform membranes nor sense curvature.
First, we have confirmed with high-speed AFM that the human
CHMP4B assembles into spirals when in contact with a negatively
charged supported lipid bilayer (SLB) made of 60% DOPC, 30%
DOPS, and 10% PI(4,5)P2 (Fig. 1a and Supplementary Movie 1).
We measured an average peak to peak distance between filaments
within a spiral to 11.3 ± 1.9 nm (N= 134) (Supplementary Fig. 2),
smaller than reported for Snf7 (17 ± 3 nm)18. Thus, CHMP4B
spirals are built up from one single, unbranched filament, forming
a tighter structure than Snf7 spirals that display inter-filament
branching18. Our ΔC truncated construct might lead to a different
molecular organization and thus branching, explaining the dif-
ference with Snf7. To test if CHMP4 can deform membranes as a
“loaded spring”45, we have employed an in vitro assay involving
deformable vesicles. We have analyzed both the membrane
deformation and the organization of CHMP4B filaments by
cryoEM. LUVs (Large Unilamellar Vesicles: 50 nm to 1 µm) made
of 70% EPC, 10% DOPE, 10% DOPS, 10% PI(4,5)P2 were incu-
bated with 1 µm CHMP4B, plunge frozen and imaged by cryo-EM
(N= 8 experiments). As displayed in Fig. 1b, CHMP4B assembles
into spirals on LUVs. The inter-filament distances within the
spirals is 7.8 ± 2.6 nm (N= 208), corresponding to peak-to-peak
distances of 11.3 ± 2.6 nm, similar to those measured with HS-
AFM. The diameter of the spirals is 193 ± 63 nm (N= 23). We did
not observe any obvious membrane budding or buckling but an
apparent flattening as compared to naked LUVs (Supplementary
Fig. 3A, B and Supplementary Movies 2A, B). To visualize any 3D
deformation, we have performed cryo-electron tomography
(cryoET) (Fig. 1c and Supplementary Movie 3) (N= 5). When
bound to membranes, CHMP4B spirals (in red) are flat without
inducing any deformation. (see side view Fig. 1c, bottom and
Supplementary Movie 3). They induce a squashing with a height
that decreases from about 150 nm for the bare liposomes (Sup-
plementary Movies 2A, B) down to about 50 nm with bound
CHMP4B (Supplementary Movie 3). This suggests that the elastic
energy stored in the CHMP4B spirals favors a non-curved
membrane and no invagination or ex-vagination.
LUVs have a positive Gaussian curvature, in contrast with the
negative Gaussian curvature of membranes in biological contexts
where ESCRT-III usually localizes (Supplementary Fig. 1a). To
study the effect of membrane geometry on ESCRT assembly, we
have used assays involving membrane nanotubes with a variety of
membrane geometries (Fig. 1d).
We have developed an approach based on laser-triggered
fusion46 that allows ESCRT-III protein encapsulation into
negatively charged GUVs28. We have encapsulated fluorescently
labeled CHMP4B inside a non-charged GUV (cyan) at a
concentration of 1 μM and fused it with a GUV containing PI
(4,5)P2 (magenta) (Fig. 1e) (for details on lipid compositions, see
Methods), leading to a reduction of the charge on the final GUV
by 2. A tube was pulled beforehand from the PI(4,5)P2-containing
GUV (Fig. 1d, iii), generating a physiologically-relevant mem-
brane geometry for CHMP4B. Tube diameters can be tuned by
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changing membrane tension with a micropipette aspirating the
magenta membrane GUV. Using this setup, we observed that
CHMP4B was neither enriched at the tube neck, nor in the tube.
We calculated the sorting ratio, i.e. the protein enrichment in the
tube as compared to the GUV, based on fluorescence47 (N= 64 in
total for 17 nanotubes). This ratio is larger than 1 for proteins
enriched and lower than 1 for proteins depleted from membrane
tubes. This quantification reveals sorting ratios lower than 1 over a
large range of tube diameters. Thus, CHMP4B is excluded from
tubes with a negative mean curvature (and a null Gaussian
curvature) and prefers to bind to the flat surface of the GUV
(Fig. 1f). Interestingly, no preferential binding was detected even
at diameters corresponding to the expected preferred curvature for
Snf7 (between 40 nm and 60 nm)17,18,20.
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We next tested binding of CHMP4B to positively curved
membranes (geometry (ii) (Fig. 1d)). CHMP4B proteins were
incubated with GUVs containing PI(4,5)P2 before a membrane
nanotube was pulled outwards (Fig. 1g). CHMP4B exhibited a
sorting ratio of the order of 1 over the full range of tube diameters
(N= 39 in total for 24 nanotubes) (Fig. 1h), indicating that
CHMP4B can bind to tubes with a positive curvature, although
no affinity for this geometry has yet been reported. Moreover, the
absence of fluorescence recovery in FRAP experiments on
nanotubes after 6 min suggests that CHMP4B forms stable
polymers, bound to the tube (Supplementary Fig. 4).
Finally, we used cryo-EM to study the organization of
CHMP4B on tubes. Our LUV preparation was generated after
a resuspension of a dried lipid film, which preserves PI(4,5)P2
lipids within the bilayer48. This methodology generates a
heterogeneous suspension of vesicles in size and geometry.
15% ± 3.4% (N= 315 vesicles) of the vesicles were spontaneously
forming tubular structures in the preparation (arrows in
Supplementary Fig. 3A, B). The addition of 1 µM CHMP4B does
not induce any further tubulation of the liposomes (20 ± 14.2%,
N= 214 vesicles). We next analyzed how CHMP4B filaments
organize on these preformed tubes. Figure 1i shows that
CHMP4B filaments bind to lipid tubes, and align along the main
axis of the tubes where the curvature is minimal, forming parallel
structures and inducing some helicity to the tubes. We have
collected images of the tubes and performed 2D averaging and
classification (Supplementary Fig. 3C). 192 sections of tubes
decorated by CHMP4 were hand-picked. Five classes were
generated by 2D processing. From the averages, repetitive
patterns can be discerned parallel to the axis of the tube
(Supplementary Fig. 3C, bottom row). We also generated rigid
galactocerebroside (GlaCer) nanotubes supplemented with 10%
(wt) EPC and 10% (wt) PI(4,5)P2 displaying an external diameter
of 25 nm49. Similarly, CHMP4B filaments polymerize on these
tubular structures and tend to be aligned along the main tube axis
(average angle equal to 8.2° ± 5.1° (±SD, N= 21), although some
twist is visible along the filaments (Fig. 1j).
Altogether, these results do not support previous models of a
stiff CHMP4B spiral acting as a loaded spring that could induce
membrane bending. Rather, they suggest that CHMP4B, in the
absence of the other ESCRT-III proteins, flattens membranes or
assembles along the main axis of tubes where the mean curvature
is null.
CHMP2B and CHMP2A/CHMP3 prefer positively curved
membranes. We next analyzed the assembly of CHMP2B and
CHMP2A/CHMP3 on membranes with specific geometries. First,
we show by HS-AFM that CHMP2B assembles onto SLBs into
ring-like structures with a diameter of 16.4 ± 3.1 nm (peak-to-
peak distance, N= 69) (Fig. 2a). Similar structures have been
reported for CHMP2A, assembled in the absence of mem-
branes19. In contrast, the in vivo over-expression of CHMP2B
induces the formation of rigid tubular membrane protrusions
stabilized by CHMP2B helical filaments25, suggesting that
CHMP2B adopts alternative geometries upon binding to mem-
branes. Furthermore, CHMP2B assembles into clusters that
localize at the neck of nanotubes pulled from GUVs, but not
inside tubes28. This suggests that CHMP2B has affinity for
negative Gaussian curvature, but not for negative mean curvature,
in contrast with in vivo over-expression conditions25. In order to
test whether CHMP2B binds to positively curved membranes, we
incorporated CHMP2B into GUVs and employed the I-BAR
protein IRSp53 to form membrane tube invaginations on another
set of GUVs50,51 (geometry (iv) (Fig. 1d)). Fusion of both GUVs
(Fig. 2b, left panel) demonstrated that CHMP2B co-localizes with
the positively curved membranes of internal tubes (Fig. 2b, right
panel) (N= 7). This is consistent with an enhanced spontaneous
tubulation (30.2 ± 1.6%) observed by cryo-EM after incubation of
LUVs with 1 µM CHMP2B. Globally, this thus shows that
CHMP2B can assemble on flat membranes and on membranes
with a positive mean curvature or a negative Gaussian curvature,
which, however, requires the presence of CHMP4 in vivo25.
CHMP2A and CHMP3 have to be present together for binding
negatively charged membranes19,52. We thus first studied whether
CHMP2A/CHMP3 assembles inside nanotubes, using the geo-
metry (iii) (Fig. 1d). In these experiments, only CHMP2A was
fluorescently labeled and CHMP3 was kept unlabeled (see ref. 52).
Proteins were reconstituted inside GUVs at low micromolar
concentrations. No binding to the inner leaflet of the membrane
nanotube was observed independently of the tube diameter
(Fig. 2c, tube diameters equal to 65 and 23 nm). We observe only
very weak binding to the flat membrane of the GUV (Fig. 2c). This
demonstrates that, CHMP2A/CHMP3 does not assemble on
negatively curved membranes and has only a very weak affinity for
membranes with a null-curvature under these conditions.
However, in the presence of spontaneously formed internal
tubules in the GUVs with a positive mean curvature (geometry
(iv) Fig. 2d), we noticed a strong enrichment of the proteins on
these structures. Conversely, we observed with cryo-EM that
these proteins generate positive membrane curvature since the
fraction of tubular structures is increased as compared to the
control (31 ± 5%) when CHMP2A (0.5 µM) and CHMP3 (3 µM)
are added.
In order to further confirm the preference of CHMP2A/
CHMP3 for positively curved membranes, we incubated GUVs
with CHMP2A/CHMP3 and pulled a nanotube outwards
Fig. 1 CHMP4-ΔC flattens LUVs and binds preferentially to flat membranes or to membranes with a positive mean curvature. a CHMP4B-ΔC spirals
observed by HS-AFM on a lipid bilayer. Scale bar: 50 nm. b Cryo-EM image of CHMP4B-ΔC spiral on deformable LUVs. Scale bar: 50 nm. c Top view (top) and
side view (bottom) of a cryo-EM tomogram (Supplementary Movie 2) showing CHMP4B-ΔC spirals (red: CHMP4 filaments polymerized on lipids; blue:
filaments polymerized in bulk; yellow: lipids). Scale bar: 200 nm. d The different geometries used to study ESCRT-III proteins/membrane interactions. The
protein location is indicated by a green shadow. (i) Proteins outside a tube, corresponding to C > 0 and K=0. (ii) Proteins outside a nanotube pulled from a
GUV: on the tube, C > 0 and K=0; on the GUV, C= K=0; and on the neck, K < 0. (iii) Proteins inside a nanotube pulled from a GUV: on the tube, C < 0 and
K=0; on the GUV, C= K=0; and on the neck, K < 0. (iv) Spontaneously formed tubule inside a GUV in geometry (iii): on the internal tube, C > 0 and K=0.
e Confocal images corresponding to a GUV fusion experiment in which CHMP4B-ΔC is binding in geometry (iii). Scale bar: 10 µm. f Sorting ratio for 17
nanotubes from 17 GUVs in 8 independent GUV preparations and variable diameters (e). For each condition, N measurements were made: <20 nm: N= 19;
20–40 nm: N= 28; 40–60 nm: N= 11; 60–80 nm: N= 6; >80 nm: N= 8. Center line: mean, box limits: SD. Red dashed line: sorting ratio equal to 1. g Confocal
images corresponding to a GUV fusion experiment where CHMP4B-ΔC binds in geometry (ii). Scale bar: 10 µm. h Sorting ratio for 24 nanotubes from 24 GUVs
in 10 independent GUV preparations and of variable diameters (g). For each nanotube diameter, N measurements were performed: <20 nm: N= 11; 20–40 nm:
N= 8; 40–60 nm: N= 5; 60–80 nm: N= 4; >80 nm: N= 11. Center line: mean, box limits: SD. Red dashed line: sorting ratio equal to 1. i Cryo-EM image of
CHMP4B polymerized outside deformable membrane nanotubes. Left: Raw image, Right: eye guide. Scale bar: 50 nm. j Cryo-EM image of CHMP4B-ΔC
filaments polymerized onto non-deformable GlaCer tubes. Left: Raw image, Right: eye guide. Scale bar: 50 nm. f, h Source data are provided as a Source
Data file.
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-16368-5
4 NATURE COMMUNICATIONS |         (2020) 11:2663 | https://doi.org/10.1038/s41467-020-16368-5 | www.nature.com/naturecommunications
(geometry (ii)). Here, CHMP2A associates in the presence of
CHMP3 with the GUV membrane as well as the outer leaflet of
the pulled membrane tube (Fig. 2e). By quantifying the sorting
ratio in this geometry, we confirmed that CHMP2A/CHMP3
bind to membrane with a positive mean curvature (N= 145 in
total, 24 nanotubes) (Fig. 2e, right). Moreover, since the sorting
ratio increases with tube curvature (the inverse of the radius) up
to about 5 for tube diameters smaller than 20 nm, it demonstrates
that the CHMP2A/CHMP3 complex can polymerize on mem-
brane in a positive curvature-dependent matter, similarly to
CHMP2B.
In agreement with these tube pulling experiments, Cryo-EM
visualization of the CHMP2A/CHMP3 assembly onto tubular
membrane structures (geometry (i); Fig. 1d) revealed a helical
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loose polymer wrapping around membrane tubes perpendicularly
to the main tube axis, both on spontaneous deformable tubes
(Fig. 2f) and on rigid GlaCer tubes (Fig. 2g). This further
demonstrates the affinity of CHMP2A/CHMP3 for membranes
with a positive mean curvature, which is different from the linear
arrangement of CHMP4B along the main axis of tubes (Fig.1i, j).
CHMP4B/2B and CHMP4B/2A/3 bind inside nanotubes’ neck. In
vivo, ESCRT-III complexes function on membranes with a
negative Gaussian curvature. We therefore co-encapsulated
CHMP4B and CHMP2B (both fluorescent) as well as CHMP4B
and CHMP2A/CHMP3 (with fluorescent CHMP4B and
CHMP2A) at low micromolar concentrations in EPC GUVs and
fused them with GUVs containing PI(4,5)P2 from which a tube
was pulled (Fig. 1d, geometry iii).
Upon fusion, in some cases, no membrane binding was detected,
probably due to a too low protein concentration. When binding
occurs, both CHMP4B and CHMP2B bind to the inner leaflet of the
GUV with a local enrichment of CHMP4B and CHMP2B at the
nanotube neck (Fig. 3a) in 66% of the cases (N= 12, 4
experiments). No protein was detected inside the nanotubes. When
internal tubular structures were present inside the GUV (geometry
iv) (4 GUVs), both proteins were found to be bound to these tubes.
In the case of CHMP4B/CHMP2A/CHMP3, slightly different
results were observed. When membrane binding was observed,
only CHMP4B was detected on the GUVs (N= 15, 9 experi-
ments). In about 30% of the cases, however, we could detect a
local enrichment of both CHMP4B and CHMP2A at the neck of
the nanotube (Fig. 3b). All the proteins were always excluded
from the interior of the nanotubes. Eventually, CHMP4B was also
often strongly bound to internal tubular structures (Supplemen-
tary Fig. 5) (90% of 10 GUVs), with only weak enrichment, if any,
of CHMP2A on these tubules.
Altogether, we have found that in the absence of other ESCRT
partners, these minimal complexes can be recruited to the neck of
membrane tube structures exhibiting a negative Gaussian
curvature. In addition, they have some affinity for membranes
with a positive mean curvature.
CHMP4B/2A/3 and CHMP4B/2B reshape vesicles into pipe sur-
faces. The complex Vps2/Vps24 was shown to induce deforma-
tion of regular Snf7 spirals assembled on non-deformable flat
SLBs33. We show here with HS-AFM that CHMP2B has a very
similar effect on CHMP4B spirals on a SLB (Fig. 3c). The
CHMP4B spirals lose their regularity upon addition of CHMP2B
(Supplementary Fig. 6 and Supplementary Movie 4). Similar
observations were also obtained with cryo-EM on flattened LUVs
(Supplementary Fig. 8A).
We next studied in real time by HS-AFM whether membrane
reshaping occurs upon ESCRT-III protein addition. In this assay,
small unilamellar vesicles (SUVs) (diameters of 60-100 nm) were
immobilized on a mica surface before CHMP4B was added
followed by CHMP2B. The addition of CHMP4B (2 µM) did not
change the spherical shape of the SUVs even after 15min
(Supplementary Fig. 7A, B). However, further addition of
CHMP2B (1 µM) induced the formation of an outward protrusion
from the vesicle (Fig. 3d, Supplementary Fig. 7C and Supplemen-
tary Movies 5A, B) over the same time period, showing that
CHMP4B with CHMP2B can mechanically deform SUVs.
These deformations were analyzed with cryo-EM over longer
time on LUVs. LUVs were incubated for 1 h with CHMP4B
(0.5–1 µM) and upon addition of either CHMP2B (0.5–1 µM, N
= 15 experiments) or CHMP2A (0.5–1 µM)/CHMP3 (1.5–3 µM)
(N= 13 experiments), for one additional hour induced, extensive
vesicle tubulation was observed (Fig. 3e and Supplementary
Fig. 8B). Close to 100% of the LUVs were tubulated under these
conditions. This concentration range is optimal since no extensive
tubulation is observed below, and protein aggregates form above.
Strikingly, both CHMP4B/CHMP2B and CHMP4B/CHMP3A/
CHMP3 remodel the vesicles into helical tubes, like a corkscrew
(a geometrical shape called a pipe surface) (Fig. 3f, h). Helical
membrane tube formation by CHMP4B/CHMP2B was confirmed
by cryoET (Fig. 3g). Both CHMP4B/CHMP2B and CHMP4B/
CHMP2A/CHMP3 helical membrane tubes revealed parallel
filaments, following the tube axis (Fig. 3f, h, i). The sequence
of protein addition is essential to trigger such membrane
reshaping. When CHMP4B and CHMP2B, or CHMP2A/
CHMP3, are added simultaneously, or when CHMP4B is added
after CHMP2B (N= 2 experiments) or CHMP2A/CHMP3 (N=
2 experiments), the helical tubular deformations no longer occur
and only flat spirals, like for CHMP4B-only (Fig. 1b), are
observed (Supplementary Fig. 8 C, 8D and 8E),. Hence, CHMP4B
has to assemble first on liposomes to nucleate the helical
membrane tube deformation by either CHMP2B or CHMP2A/
CHMP3.
Figure 3k schematizes the pipe surface of the membranes upon
binding of the ESCRT-III, where w is the width of the spiral, ϕ the
diameter of the tube and d the distance between adjacent parallel
filaments on the tube. We found that the width w is conserved
and equal to 115.1 ± 16.2 nm (N= 66) for CHMP4B/CHMP2B
and 110.9 ± 20 nm (N= 66) for CHMP4B/CHMP2A/CHMP3.
The diameters of the tubular structures are displayed in Fig. 3l. The
diameters of the tubes decorated by CHMP4B only (ϕ = 37.4 ±
14 nm, N= 43) are significantly larger than the tubes induced in
combination with CHMP2B (ϕ = 26.2 ± 4.4 nm, N= 107) or
CHMP3/CHMP2A (ϕ = 27.9 ± 11 nm, N= 233), suggesting that
the final organization of the proteins on the membrane constricts
the tubes. In contrast, the distance between filamentous structures
parallel to the tube axis is similar for CHMP4B/CHMP2B
samples (d= 4.2 ± 1.1 nm (N= 60)), for CHMP4B/CHMP2A/
CHMP3 samples (d= 4.4 ± 1.2 nm (N= 66)) and for CHMP4B
only (d= 4.4 ± 0.8 nm (N= 31)) (Fig. 3m). In addition, striations
Fig. 2 CHMP2B-ΔC and CHMP2A-ΔC/CHMP3 essentially assemble on positively curved tubes. a HS-AFM image of CHMP2B-ΔC rings on a flat, non-
deformable SLB. The quantification of ring diameters is shown. b Confocal images corresponding to a GUV fusion experiment in which CHMP2B-ΔC is
exposed to a geometry (iv) induced by the I-BAR domain of IRSp53 (non-fluorescent), tubulating the membrane when present on the exterior of the GUV.
N= 7. Scale bar: 10 µm. c Confocal images corresponding to a GUV fusion experiment in which CHMP2A-ΔC+ CHMP3 are binding in geometry (iii).
CHMP3 is unlabeled. Left GUV: tube diameter = 65 nm. Right GUV: tube diameter = 23 nm. Scale bars: 10 µm. d Confocal images corresponding to a GUV
fusion experiment in which CHMP2A-ΔC+ CHMP3 are binding in geometry (iv), showing the affinity of the assembly for internal positively curved tubes.
Scale bar: 10 µm. e Left: Confocal images corresponding to a GUV fusion experiment in which CHMP2A-ΔC+ CHMP3 are binding in geometry (ii).
CHMP3 is unlabeled. Scale bar: 10 µm. Right: Quantification of the sorting ratio for 24 nanotubes of variable diameters from 25 GUVs in 9 independent
GUV preparations. For each nanotube diameter, N measurements have been performed: <20 nm: N= 20; 20–40 nm: N= 74; 40–60 nm: N= 41; 60–80
nm: N= 6; >80 nm: N= 4. Center line: mean, box limits: SD. The red dashed line corresponds to a sorting ratio equal to 1. Scale bar: 10 µm. f Cryo-EM
image of CHMP2A-ΔC/CHMP3 filaments polymerized outside deformable membrane nanotubes. Top: Raw image, Below: Guide for the eyes. Scale bar:
50 nm. g Cryo-EM image of CHMP2A-ΔC/CHMP3 filaments polymerized outside non-deformable GlaCer tubes. Top: Raw image, Bottom: Guide for the
eyes. Scale bar: 50 nm. a, e Source data are provided as a Source Data file.
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perpendicular to the long axis of the tubes are also present
(Fig. 3j, arrows). To further quantify this observation, we have
performed 2D classification out of 350 sub-portions of tubes for
the CHMP4B/CHMP2B sample (Fig. 3n, top). The 10 resulting
classes and the resulting Fourier transformation show unambig-
uous evidence for periodical structures both along the axis of the
tubes (red line) and perpendicular to the tube (blue line, 20% of
the dataset) (Supplementary Fig. 8F). In Fourier space, all classes
generated peak densities along the direction related to the tube
axis (red) (Fig. 3n, bottom and Supplementary Fig. 8F),
corresponding to a repetitive pattern of consecutive filaments
with a mean distance of 3.5 ± 0.3 nm, averaged from the 10
classes, similar to our image analysis (Fig. 3m). In addition,
diffraction peaks indicating a repeated distance perpendicular to
the axis of the tubes (blue) (Fig. 3n) were also present for 20% of
the obtained classes (3 classes) (Supplementary Table 1). We
obtained 3.2 ± 0.4 nm. Note that no such orthogonal structures
were detected with CHMP4B only (Supplementary Fig. 3C).
Hence, two sets of perpendicular filaments are bound to the pipe
surface: a first set of parallel filaments along the main axis of the
helical tube and locally, on about 20% of the total tube length, a
second set of perpendicular filaments, possibly influencing its
diameter (Fig. 3l).
To uncover the arrangement of the ESCRT-III proteins at
nanometer scales, we carried out cryoET, followed by sub-
tomogram averaging, of CHMP4/CHMP2B-induced tubular
structures. Four different populations of filaments decorating
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exhibits exclusively one type of filament arrangement and no
mixed arrangements coexist within the same “pipe”. The first,
comprising one third (34%) of the analyzed structures, does not
display any organized patterned architecture. The second (Fig. 4a)
is composed of individual protein filaments that decorate the
pipes in a homogeneous fashion. This group was the predominant
ordered architecture observed in the sample (33%). Indeed, after
averaging lipid tubes using their whole sections (Supplementary
Fig. 9A), we observed that 14 filaments decorate the tubular
structure in a periodic and regular pattern, independent of the
curvature (Supplementary Fig. 9A, Supplementary Movies 6 and
7). The reconstruction was obtained at a resolution of 26.1 Å (See
FSC curve in Supplementary Fig. 9B). The third population
consists of paired filaments that were found in only 3% of the
dataset (Fig. 4b) and its final average was determined at a
resolution of 26.1 Å (see FSC, Supplementary Fig. 9B) (Supple-
mentary Movie 8), Interestingly, multireference analysis (MRA),
resulted in different classes grouped according to their distribu-
tion along the pipe (Supplementary Fig. 9C: class 1 and class 2).
Class 1 corresponds to negatively curved portion of tubes (inner
side), where filaments are scarce (Supplementary Fig. 9D). Class 2
corresponds to filaments bound to the outer side of tubes
(positive curvature) with a higher density, suggesting that paired
ESCRT filaments have a higher affinity for positively curved
membranes. A similar asymmetric distribution has been
described in a recent report on yeast ESCRTs53. The fourth
population, comprising the remaining 30% of the dataset, is
composed of filaments bridged by protein connections perpendi-
cular to the main axis of the tubes (see Fig. 4c, arrows)
(Supplementary Movie 9). Its final average was determined at
28.3 Å resolution. This set of bridging proteins is most likely
related to the striations perpendicular to the main axis of the lipid
tubes visualized in Fig. 3j, highlighted by diffraction spots
perpendicular to the main axis of lipid tubes (Fig. 3n).
Taken together, our analyses demonstrate that the observed
macroscopic tubulation into a corkscrew-like architecture is
driven by distinct nanometer ultra-structures of ESCRT filaments.
Discussion
Membrane remodeling by ESCRT-III polymers implicates in
many cases negative Gaussian membrane curvature. It has been
shown that ESCRT-III assembles at or inside bud necks of
endosomal vesicles10, enveloped viruses36,39,40 and within the
cytokinetic midbody41,43. Less is known about membrane shape
requirements or effects of ESCRT-III recruitment during the
other ESCRT-catalyzed membrane remodeling processes. Inter-
action with positively curved membranes has been so far only
reported for ESCRT-III CHMP1B that forms helical structures on
membrane tubes in vitro and in vivo on endosomal tubular
extensions54–56. Our results reveal that neither CHMP4B,
CHM2A/CHMP3 nor CHMP2B have on their own affinity for
membranes with a mean negative curvature. Instead, we show
that CHMP4B assembles into spirals on flat membranes similar
to yeast Snf718. However, CHMP4B alone does not deform
membranes. Polymerization into spiral structures on the posi-
tively curved membranes of LUVs only leads to membrane flat-
tening, but no membrane buckling occurs under these conditions
in contrast to theoretical predictions18,45, suggesting that the
filaments made of CHMP4B have a low bending rigidity (see
also53). Upon incorporation of CHMP4B inside GUVs with
membrane tubes pulled outwards, CHMP4B does not concentrate
at the tube as observed at the bud neck under CHMP2 double
knockdown HIV-1 budding conditions36. Thus, functional
CHMP4B recruitment to membrane necks may require prior
assembly of ESCRT-I and ESCRT-II complexes or Alix that
coordinate the assembly of CHMP4B filaments57,58 or enhance
CHMP4B affinity for the membrane, rather than CHMP4B
having a preference for certain membrane curvatures30,31. In
contrast, CHMP4B assembles on the outside of membrane tubes,
thereby forming filaments parallel to the tube axis where mean
membrane curvature is zero. The large-scale twisting of the
CHMP4B-decorated flexible membrane tubes further supports
the helical nature of the CHMP4B filaments.
Strikingly, we have shown that both CHMP2A/CHMP3 and
CHMP2B do not assemble inside tubes but rather polymerize on
the outer side of membrane tubes. Moreover, high positive cur-
vature enhances CHMP2A/CHMP3 polymerization that forms
helical filaments wrapping around tubes, perpendicular to the
tube axis. Although the structure of the polymers appears more
lose than for CHMP1B26, it establishes that not only CHMP1B
interacts with positive curved membranes, but also ESCRT-III
core members. Notably, the latter have been implicated in vivo in
membrane remodeling with an opposite membrane geometry.
Only the combination of CHMP4B/CHMP2B or CHMP4B/
CHMP2A/CHMP3 is found occasionally enriched at the neck of
membrane nanotubes consistent with the proposal that a CHMP4
polymer forms a platform for downstream ESCRT-III
assembly9,36. In addition, CHMP2A-CHMP3 and CHMP2B
systematically remodel CHMP4B-bound LUVs into regular
helical tubes with pipe surfaces. Three-dimensional helical poly-
meric structures have also been reported in the absence of
membranes for Snf7, Vps2 and Vps2420,59, and for CHMP2A/
CHMP319. For both CHMP4B/CHMP2B or CHMP4B/
CHMP2A/CHMP3, the width w of the ESCRT-III helices is in the
Fig. 3 Complexes are recruited inside tube necks and reshape liposomes into helical tubes. a Representative confocal images of GUVs in geometry (iii):
preferential recruitment of CHMP4B-ΔC and CHMP2B-ΔC inside the tube neck. Scale bar: 5 µm. b Same as (a): preferential recruitment of CHMP4B-ΔC and
CHMP2A-ΔC(+CHMP3) inside the tube neck. Scale bar: 5 µm. c Effect of CHMP2B-ΔC addition to a CHMP4B spiral on a flat SLB, imaged by HS-AFM. Scale
bar: 50 nm. d Deformation of a small liposome first incubated with CHMP4B-ΔC, after addition of CHMP2B-ΔC imaged by HS-AFM (snapshots from
Movie S5A). Scale bar: 100 nm. e Effect of CHMP2B-ΔC addition to liposomes pre-incubated with CHMP4B-ΔC, imaged by Cryo-EM at low magnification.
Scale bar: 500 nm. f Details of a helical tube structure induced by CHMP4B-ΔC+CHMP2B-ΔC. Scale bar: 50 nm. g Cryo-EM tomogram of a helical tube
structure formed by CHMP4B-ΔC+CHMP2B-ΔC (Top). Scale bar: 200 nm. Bottom: segmentation of the tubular membrane (yellow) from the cryo tomogram
above. Scale bar: 200 nm. h, i Helical tubes induced by CHMP4B-ΔC+CHMP2A-ΔC+CHMP3. Scale bar: 50 nm. j Zoom corresponding to the black frame in
Fig. 3i. Scale bar: 20 nm. k Scheme of the helical tubes. w: width of the spiral, ϕː diameter of the tube and d: distance between parallel filaments. lMeasurement
from the Cryo-EM images of the tube diameters ϕ for CHMP4B-ΔC (N= 43), CHMP4B-ΔC/CHMP2B-ΔC (N= 107, p= 4.5 × 10−6) and CHMP4B-ΔC/
CHMP2A-ΔC/CHMP3 (N= 233, p= 7.4 × 10−5). Center line: mean, box limits: SD. m Measurement from the Cryo-EM images of the distance d between
filaments parallel to tube axis for CHMP4B-ΔC (N= 31), CHMP4B-ΔC/CHMP2B-ΔC (N= 66) and CHMP4B-ΔC/CHMP2A-ΔC/CHMP3 (N= 32). Center
line: mean, box limits: SD. n Top: Class-average of helical tube sections (sub-class #3 in Supplementary Table 1) formed by CHMP4B-ΔC/CHMP2B-ΔC. Blue
arrows: distance between 2 structures parallel to the tube axis; red arrows: distance between 2 structures perpendicular to the tube axis (See Supplementary
Fig. 8F). Scale bar: 10 nm. Bottom: Fourier-Transform (FT) with the distances corresponding to the Bragg peaks. Left: Raw data. Right: The red line represents the
direction of the tube axis and the blue line to the perpendicular direction along the tube section. l, m Source data are provided as a Source Data file.
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a b c
Fig. 4 Sub-tomogram averaging of CHMP4B-ΔC/CHMP2B-ΔC decorated pipes. Populations of ESCRT filaments bound to tubular membranes resulting
from sub-tomogram averaging. Upper line: orthoslices viewed from the cross sections of tubes. Second line: orthoslices viewed from the top of tubes. Third
line: 3D reconstructions viewed from the cross sections of tubes. Fourth line: reconstructions viewed from the top of tubes. Bottom line: schematic
representations of the CHMP4B-ΔC/CHMP2B-ΔC-decorated pipes. Scale bars: 10 nm. a Single ESCRT individual filaments bound to lipid tubes. Inner tube
diameter: 14.8 nm, outer tube diameter: 21.7 nm. Protein density diameter: 30.2 nm. Reconstruction from 1721 particles. b Paired ESCRT filaments bound to
lipid tubes. Inner tube diameter: 15.4 nm, outer tube diameter: 21.7 nm. Reconstruction from 524 particles. c High density of filaments bound to lipid tubes.
Inner tube diameter: 18.5 nm, outer tube diameter: 25.4 nm. Reconstruction from 381 particles. Arrows point to structures perpendicular to the tube axis.
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order of 110 nm, thus about twice larger than the preferred one
for Snf718,20 or CHMP4B23,24. These tubular structures have a
smaller diameter than the occasional tubes observed with
CHMP4B alone, suggesting particular mechanical properties of
the mixed polymers. The mechanism behind such a massive
membrane remodeling is yet unclear. Using sub-tomogram
averaging, we could sort the architecture of the CHMP assem-
blies on the pipe surfaces at nanometer scales in two main
categories, single filaments and filaments with perpendicular
connections, and an additional minority made of double fila-
ments, although all leading to the same macroscopic membrane
geometry. This indicates that only a limited set of filaments may
be required to induce this helical tubular structure. The resolution
of the current structures does not permit to conclude
whether the filaments are formed by open or closed CHMP
conformations11,12,26,27. Using budding yeast ESCRT-III pro-
teins, a paper in the same issue of the journal reports that Snf7,
VPS2 and Vps24 (10 μM: 5 μM: 5–10 μM) forms similar
corkscrew-like membrane tube structures53, suggesting that this
remodeling capacity of ESCRT-III is conserved among species.
However, in this report, the global membrane shape transfor-
mation was essentially attributed to filament doublets non-
homogeneously distributed around the tube, with different
adhesion energy depending on the face in contact with the
membrane. The authors propose that the possibility for the fila-
ments to tilt and roll on the membrane for optimizing their
binding can generate torque on the filament axis that can produce
constriction and scission60. This type of structure, however,
represents only a very minor fraction of the organizations that we
have observed with human ESCRTs, suggesting that other
mechanisms can also shape vesicles in to pipe surfaces. In con-
trast, on at least one third of the surface of the spiraled tubes, we
observe a combination of filaments aligned along the helical tube
axis crosslinked by orthogonal structures. This sort of scaffold
that combines both trends of CHMP4B to form a wide spiral
organization and of CHMP2A/CHMP3 to wrap around tubes,
can explain the emergence of the pipe surface geometry for the
membrane, although what sets the tube diameter is unclear. The
respective protein compositions of the perpendicular structures
might also be different, but at this stage we cannot distinguish
them. In addition, a large fraction of the surface is covered with
single filaments regularly distributed around the tube diameter,
without any apparent connection between them. It is possible that
the connections between filaments are too scarce or too dis-
organized to be detected. Nevertheless, altogether our results and
those from von Filseck et al53 show that the pipe shape constitutes
a robust membrane deformation that occurs over a large range of
protein concentrations, with proteins from different species.
Although the helical tubular shape of the membrane may be far
from membrane geometries where these core ESCRT-III proteins
have been localized in vivo, it nevertheless reveals the mechanical
stresses that these protein assemblies exert on membranes. The
pipe surface represents the membrane shape that minimizes the
mechanical energy of the system in the absence of any external
constraints. It also shows the capacity of the proteins to assemble
onto an “outside-in” geometry, similarly to CHMP1B and IST15.
Nevertheless, when overexpressed in human cells, CHMP4B
induces tubules with an “in-outside” geometry5,23. In vivo,
CHMP4B is recruited to the membrane via CHMP6, which in
turn is recruited by ESCRT-II and ESCRT-I or by Alix1,2,5,7.The
ESCRT-III proteins may be then forced to assemble in a non-
optimal geometry and in return exert mechanical forces on the
neck structure to release frustration. How these reciprocal inter-
actions combined to the protein turn-over due to the VPS4
ATPase and the possible constrictive action of CHMP1 and
IST137,56 lead to membrane scission remains to be established.
Here we provide novel insight on how mechanics and geometry
of the membrane and of ESCRT-III assemblies can generate
forces to shape a membrane neck.
Methods
Reagents. Common reagents were purchased from VWR reagents. L-α-
phosphatidylcholine (EPC, 840051P), 1,2-dioleoyl-sn-glycero-3-phosphocholine
(DOPC, 850375P), Cholesterol (700000P), 1,2-dioleoyl-sn-glycero-3-phos-
phoethanolamine (DOPE, 850725P), 1,2-dioleoyl-sn-glycero-3-phospho-L-serine
(DOPS, 840035P), L-α-phosphatidylinositol-4,5-bisphosphate (PI(4,5)P2,
840046P), 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(biotinyl) (PE-Bio-
tin, 870282P) and 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine
rhodamine B sulfonyl) (Rhod-PE, 810150P) were purchased from Avanti polar.
Gold nanorods Streptavidin-conjugated gold nanorods (C12-10-850-TS-DIH-
50) were purchased from Nanopartz™.
Streptavidin-coated polystyrene beads (diameter 3.2 μm) for the tube pulling
experiments were purchased from Spherotech.
Recombinant proteins. CHMP3 (full length) was expressed in Escherichia coli
BL21 cells (New England BioLabs, # C2530H) for 3 h at 37 °C11. Briefly, cells were
harvested by centrifugation (4000g for 20 min at 4 °C) and the bacterial pellet was
resuspended in 50 ml of binding buffer A (20 mM Bicine pH 9.3, 300 mM NaCl,
5 mM imidazole, 1% CHAPS/1 mM PMSF). The bacteria were lysed by sonication
and CHMP3-FL was purified by Ni2+ chromatography. A final gel filtration
chromatography step was performed in buffer B (20 mM Hepes pH 7.6, 150
mM NaCl).
CHMP2A-ΔC containing residues 9–161 was expressed as MBP-fusion protein
in Escherichia coli BL21 cells61 for 1 h at 37 °C. Cells were harvested by
centrifugation (4000g for 20 min at 4 °C) and the bacterial pellet was resuspended
in 50 ml of binding buffer C (20 mM Hepes pH 7.6, 300 mM NaCl, 300 mM KCl).
The bacteria were lysed by sonication, and CHMP2A-ΔC was purified on an
amylose column. CHMP2A-ΔC was labeled overnight at 4 °C with Alexa Fluor 405
NHS Ester (Thermo Fisher Scientific) using a molar ratio (Alexa Fluor:protein) of
2:1. A final gel filtration chromatography step was performed in a buffer B.
CHMP3-FL and CHMP2A-ΔC were concentrated to 20 μM, and immediately
frozen in liquid nitrogen with 0.1% of methyl cellulose (Sigma-Aldrich) as cryo-
protectant. All aliquots were kept at −80 °C prior to experiments.
CHMP2B-ΔC, containing amino acids 1–154 and a C-terminal SGSC linker for
cystein-specific labeling62, was expressed in Escherichia coli BL21 cells for 4 h at
37 °C. Cells were lysed by sonication in buffer D (50 mM Tris-HCl pH 7.4, 1 M
NaCl, 10 mM DTT and protease inhibitor (Complete EDTA free, Roche) at the
concentration indicated by the manufacturer) and the soluble fraction was
discarded after centrifugation (50,000g, 20 min, 4 °C). The pellet was washed three
times with buffer E (50 mM Tris-HCl pH 7.4, 2 M urea, 2% Triton X-100 and
2 mM β-mercaptoethanol). The last wash was performed in absence of urea and
Triton X-100. The extraction of CHMP2B was performed in 50 mM Tris-HCl
pH 7.4, 8 M guanidine, 2 mM β-mercaptoethanol overnight at 4 °C. After
centrifugation (50,000g, 20 min, 4 °C), CHMP2B was purified by Ni2+-chromato-
graphy in buffer F (50 mM Tris-HCl pH 7.4, 8 M urea). The protein was eluted in
50 mM Tris-HCl pH 7.4, 8 M urea, 2 mM β-mercaptoethanol, 250 mM imidazole.
Refolding was performed by rapid dilution of CHMP2B into buffer G (50 mM Tris-
HCl pH 7.4, 200 mM NaCl, 2 mM DTT, 50 mM L-glutamate, 50 mM L-arginine)
and a final concentration of 2 μM. CHMP2B was concentrated by passing it over a
Ni2+ column in buffer H (50 mM Tris-HCl pH 7.4, 200 mM NaCl) and eluted in
buffer I (50 mM Tris-HCl pH 7.4, 300 mM NaCl, 250 mM imidazole). CHMP2B
was labeled overnight at 4 °C with Alexa Fluor 488 C5 Maleimide (Thermo
Scientific) with a molar ratio (Alexa Fluor:protein) of 2:1. A final gel filtration
chromatography step was performed on a superdex75 column in buffer J (50 mM
Tris-HCl pH 7.4, 100 mM NaCl). The protein was concentrated to 20 μM, and
immediately frozen in liquid nitrogen with 0.1% of methyl cellulose (Sigma-
Aldrich) as a cryo-protectant. All aliquots were kept at −80 °C prior to
experiments.
CHMP4B-ΔC, containing residues 1–175 followed by a linker of 20 aa
(SNSASDDASASASADEDASS) and CHMP4B residues 204–224, was expressed as
MBP fusion protein16 in Escherichia coli BL21 cells for 2 h at 37 °C. Cells were
harvested by centrifugation (4000g for 20 min at 4 °C) and the bacterial pellet was
resuspended in 50 ml of binding buffer K (50 mM Hepes pH 7.6, 300 mM NaCl,
300 mM KCl). The bacteria were lysed by sonication. The CHMP4B protein was
purified on an amylose column. CHMP4B was labeled overnight at 4 °C with Alexa
555 succimidyl ester or 633 succimidyl ester (Thermo Fisher Scientific) using a
molar ratio (Alexa Fluor:protein) of 2:1. A final gel filtration chromatography step
was performed in the buffer KJ. CHMP4B were concentrated to 15 μM and
immediately frozen in liquid nitrogen with 0.1% of methyl cellulose (Sigma
Aldrich) as cryo-protectant. All aliquots were kept at −80 °C prior to experiments.
Cryo-electron microscopy sample preparation and imaging. A lipid mixture
(70% EPC, 10% DOPE, 10% DOPS, 10% PI(4,5)P2) at 1 mgmL−1 was quickly
dried under argon for 2 min and next under vacuum for 30 min. LUVs (Large
Unilamellar Vesicles) of variable size (50–500 nm) were obtained by resuspension
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and vortexing of the lipid film after addition of a buffered solution to reach a final
concentration of 0.1 mgmL−1. Different combinations of CHMP proteins were
incubated with the vesicles at room temperature for 1 h. We used CHMP4B,
CHMP2B and CHMP2A at a concentration of 0.5 or 1 µM, and CHMP3 at a
concentration of 1.5 or 3 µM, in the buffer 25 mM Tris HCl pH 8, 50 mM NaCl,
containing the AcTEV protease (Thermofisher scientific) in excess. For the protein
mixtures, we used a ratio of 1:3 for CHMP2A/CHMP3, 1:1 for CHMP4B/
CHMP2B, and 1:1:3 for CHMP4B/CHMP2A/CHMP3, respectively. A 4 µL drop of
the solution was deposited on a glow discharged lacey carbon electron microscopy
grid (Ted Pella, USA). Most of the solution was blotted away from the grid to
leave a thin (less than 100 nm) film of aqueous solution. The blotting was carried
out on the opposite side from the liquid drop and plunge frozen in liquid ethane at
−181 °C using an automated freeze plunging apparatus (EMGP, Leica, Germany).
The samples were kept in liquid nitrogen and imaged using three different
microscopes. A Tecnai G2 (FEI, Eindhoven, Netherlands) Lab6 microscope oper-
ated at 200 kV and equipped with a 4k × 4k CMOS camera (F416, TVIPS) was used
(Institut Curie) at a magnification of 50,000 with a pixel size of 2.13 Å and a dose
per image of 15 electrons per Å2. Some of the imaging was performed as well on a
200 kV FEG microscope equipped with a direct detector (Falcon camera) (Institut
Pasteur) at a 50,000 magnification with a pixel size of 2 Å and a dose per image of
15 electrons per Å2. A 300 kV FEG (Field Emission Gun) POLARA microscope
(FEI, Eindhoven, Netherlands) equipped with an energy filter and a direct detector
(K2 camera, Gatan) was also employed (IBS, Grenoble). In this case, the imaging
was performed at a magnification of 81,000 with a pixel size of 1.21 Å using a
movie mode collecting 40 successive frames for a total dose of 50 electrons per Å2.
The different frames were subsequently aligned.
Cryo-electron tomography. The samples were prepared as described above. 10 nm
size gold beads were added to the solution before being plunge frozen. Tilt series
were collected in low dose mode, every two degrees, using a Tecnai G2 (FEI,
Eindhoven, Netherlands) microscope operated at 200 kV and equipped with a 4k ×
4k CMOS camera (F416, TVIPS) (Institut Curie). To preserve the information and
minimize irradiations at low tilt angles, the following angular scheme was applied:
from 0° to 34°, then from −2° to −60° and finally from 36° to 60°. The dose per
image was 0.8 electrons per Å2. The imaging was performed at a magnification of
50,000 and each image was binned twice for a final pixel size of 4.26 Å. The
consecutive images were aligned using the IMOD software suite63. Back projection
was performed using IMOD and SIRT reconstruction was carried out using
Tomo3d. The segmentation was performed manually using IMOD.
The dataset used for sub-tomogram averaging consisted of 28 tilt-series
collected at the Electron Microscopy Core Facility of the European Molecular
Biology Laboratory (EMBL) in Heidelberg. Image acquisition was performed on a
Titan Krios microscope (FEI) operated at 300 kV using a Quantum post-column
energy filter and a Gatan K2 Summit direct detector controlled by SerialEM64. Tilt-
series were collected using the dose-symmetric scheme (Hagen et al. 2017) in the
range of ±60° and a 3° angular increment and a defocus range between −1.5 and
−4.25 μm. Tilt images consisted of 13 super-resolution frames with a total dose per
tilt-series of 140 e−Å−2. Alignment of tilt images based on gold fiducials, CTF
estimation (CTFPlotter) and CTF correction (CTFPhaseFlip) were achieved using
the IMOD suite63,65. Tomograms were reconstructed by the weighted back-
projection method applied over the CTF-corrected aligned stacks in IMOD. Bin
4×(pixel size = 5.3 Å) tomograms were reconstructed using the SIRT-like filtering
method with 50 iterations to facilitate identification of membrane bilayers during
catalogue annotation. Protein-induced tubes were identified and annotated in
Dynamo66,67 as filaments around axis. Tube radius was determined upon aligning
and averaging particles cropped from the tube axis as the center of sub-volumes of
88 pixels (46.6 nm) using as alignment mask a cylinder of 22 nm radius. Then, the
center of the box was displaced to the tube’s membrane surface and the selected
oversampling geometry was 16 cropping points per radius separated by 6 pixels
along the tube axis. Reference free sub-tomogram averaging was performed on sub-
volumes of 343 nm in Dynamo.
Lipid mixture preparation for GUVs. Lipid stock solutions were mixed at a total
concentration of 1 mg/ml in chloroform with following molar ratio: 54.7% EPC;
10% DOPS; 10% DOPE; 15% cholesterol; 10% PI(4,5)P2; 0.2% DSPE-PEG2000-
Biotin; 0.1% PE–Rhodamine for the charged GUVs and 98.8% EPC, 0.2% DSPE-
PEG2000-Biotin for the non-charged GUVs (containing encapsulated proteins).
Protocol for GUVs preparation. GUVs were prepared with the PVA gel-assisted
swelling method as previously described68. Briefly, PVA gel (5% Poly(vinyl alco-
hol)), 50 mM Sucrose, 25 mM NaCl and 25 mM Tris-HCl, at pH 7.4) was deposited
on plasma cleaned (PDC-32G, Harrick) glass coverslips (18×18 mm, VWR Inter-
national, France) and dried for 50 min at 60 °C. 15 µl of lipid solutions at 1 mg/ml
were deposited on the PVA-coated slides and residual solvent was removed under
vacuum for 20 min at room temperature. The lipid film was then rehydrated at
room temperature for 45 min with the appropriate GUV growth buffer: 100 mM
sucrose and 50 mM NaCl for the experiments with proteins in the external med-
ium, and buffers listed in the Supplementary Tables 2–5 for the experiments with
encapsulated proteins.
GUVs with proteins in the external medium. All proteins have been incubated
with GUVs at a concentration of 500 nM in a buffer containing 100 mM glucose,
25 mM Tris pH 7.4 and 50 mM NaCl for 30′ together with 10 nM TEV, which was
sufficient to cleave at least 90% of the MBP tags in 15′ at room temperature (not
shown).
GUVs with encapsulated proteins. All proteins were co-encapsulated with pur-
ified recombinant TEV protease at a final concentration of 10 nM, which was
sufficient to cleave at least 90% of the MBP tags in 15′ at room temperature (not
shown). Growth and observation buffers have been adjusted (Supplementary
Tables 2–5) to each specific protein or proteins combination in order to balance the
osmotic pressure. The final protein concentration and ratios between proteins
results from the balance between a number of factors, such as maintaining a final
NaCl concentration of ~50 mM after fusion (each protein is stored in a different
storage buffer and at a different concentration). This is similar to the experiments
with protein binding outside of the GUVs, maintaining a sufficient amount of
sucrose inside the GUV to allow for its sedimentation in the observation chamber
and finally avoiding protein inhibition. Indeed, in co-encapsulation experiments,
CHMP4B binding to membrane was inhibited by CHMP2A if CHMP4B/CHMP2A
ratio was raised above ~2:1, in line with previous work showing capping activity of
Vps2 towards Snf733.
Practically, CHMP4B stock solution being at 300 mM NaCl + 300 mM KCl,
after addition of about 60 µl of CHMP4B, the encapsulation mixture has a salt
concentration of ~100 mM. Thus, after fusion with a PI(4,5)P2 vesicle of equal size,
the salt concentration drops to ~50 mM.
For, CHMP2A and CHMP3, both stock solutions are at 150 mM NaCl. After
addition of 80 µl of CHMP2A and 50 µl of CHMP3, the encapsulation mixture has
a NaCl concentration of ~90 mM. After fusion with a PI(4,5)P2 vesicle of equal
size, the NaCl concentration drops to about 45 mM.
After addition of 50 µl of CHMP4B, 30 µl of CHMP2A and 20 µl of CHMP3,
the encapsulation mixture has a NaCl concentration of about 100 mM. After fusion
with a PI(4,5)P2 vesicle of equal size, the salt concentration drops to ~50 mM.
Similarly, CHMP4B and 50 µl of CHMP2B, the encapsulation mixture has a
NaCl concentration of ~100 mM. After fusion with a PI(4,5)P2-containing vesicle
of equal size, the salt concentration drops to ~50 mM.
The final protein concentrations in the GUVs after fusion are listed in
Supplementary Table 6.
The fusion procedure was performed as previously described28 (see ref. 69 for a
detailed protocol). Briefly, for each experiment, two types of GUVs extracted from
each PVA slide were mixed with the relative external buffer matching the
osmolarity and centrifuged for 10 min at 1000g. GUVs taken from the bottom of
the Eppendorf were incubated with gold nanorods 20 min at room temperature
and then added to the imaging chamber.
Gold nanorods Streptavidin-conjugated gold nanorods have a peak of
absorption at λ= 834 nm, with a tail spanning the wavelength of the infrared laser
of the optical tweezers (λ= 1064 nm). The stock solution (typical concentration
1750 ppm) was diluted 1:100 upon incubation with GUVs and again diluted 1:40
when GUVs were transferred to the observation chamber.
Fusion of GUV pairs coated with the gold nanorods is achieved by bringing the
GUVs hold by two micropipettes into close contact with micromanipulation and
by locally heating the nanorods by focusing the infrared laser on the contact
through the objective.
Tube pulling experiments. The tube pulling experiments and analysis have been
performed as described in detail in refs. 47,69. Briefly, for experiments probing the
affinity of the proteins for positive curvature, the tube was formed by bringing
briefly the GUV coated with proteins in contact with a streptavidin-coated bead
trapped with the optical tweezer and moved away. For experiments involving
encapsulation and fusion, the tube was pulled from the PI(4,5)P2-containing GUV
prior to fusion, using a streptavidin-coated bead hold by a third micromanipulator.
Fusion was then performed between the GUV pair, keeping the membrane tube
in place.
The values of tube diameter (in nm) were deduced from the lipid fluorescence
intensities the tube in comparison with the fluorescence in the GUV, after
calibration:





where I lipidtube and I
lipid
GUVrepresent the fluorescence intensities of the lipids in the tube
and in the GUV, respectively.







where Iproteintube and I
protein
GUV represent the fluorescence intensities of the proteins in the
tube and in the GUV, respectively.
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High-speed AFM. All HS-AFM data were taken in amplitude modulation mode
using a sample scanning HS-AFM [Research Institute of Biomolecule Metrology
(RIBM), Japan]. Short cantilevers (USC-F1.2-k0.15, NanoWorld, Switzerland)
with spring constant of 0.15 N/m, resonance frequency around 0.6 MHz, and a
quality factor of ∼2 in buffer were used. The cantilever-free amplitude is 1 nm
(3 nm for imaging liposomes), and the set-point amplitude for the cantilever
oscillation was set around 0.8 nm (2.7 nm for liposomes). Unless mentioned, all the
HS-AFM recordings were performed in buffer containing 25 mM Tris pH 7.4 and
50 mM NaCl.
The HS-AFM experiments on supported lipid bilayers were performed with
SLBs composed of 60% DOPC, 30% DOPS, and 10% PI(4,5)P2. The SLBs were
formed by incubating LUVs on top of freshly cleaved mica, as described in ref. 35.
Briefly, LUVs were thawed at room temperature and diluted to a concentration of
0.2 mg/ml in buffer (25 mM Tris, pH 7.4, 50 mM NaCl). Then the LUVs were
incubated onto the freshly cleaved mica for 5–10 min, and rinsed with the same
buffer afterwards. After formation of SLBs, the surface was imaged without
addition of protein. While imaging the SLB, the proteins were added to the AFM
liquid chamber to reach a final concentration of 2 µM for CHMP4B, and 1 µM for
CHMP2B. The formation of CHMP4B spirals on SLBs occurred within 10 minutes
after incubation. To capture the effect of CHMP2B on CHMP4B spiral, CHMP2B
was only added after the formation of CHMP4B spirals was confirmed by HS-AFM
imaging.
The HS-AFM experiments for dynamic membrane deformation were
performed using liposomes (SUVs) composed of 50.7% EPC; 10% DOPS; 10%
DOPE; 15% cholesterol; 10% PI(4,5)P2; 0.2% DSPE-PEG2000-Biotin; 0.1%
PE–Rhodamine. The SUVs were obtained by sonicating a LUV mixture for 30 s.
The SUVs were incubated for 5 min on freshly cleaved mica, and imaged under
HS-AFM. Then, CHMP4B was added to reach a final concentration of 2 µM in the
chamber. Later, CHMP2B (at a final concentration of 1 µM) was added, but only
after confirmed spiral formation (typically after 10 min of CHMP4B addition) on
randomly formed membrane patches on mica surface. All the HS-AFM images
were processed with Igor Pro with a built-in script from RIBM (Japan), and ImageJ
software. Unless otherwise mentioned, all reported values are presented as
mean ± SD.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
Data supporting the findings of this manuscript are available from the corresponding
authors upon reasonable request. A reporting summary for this Article is available as a
Supplementary Information file. The source data underlying Figs. 1f, h, 2a, e, 3l, m,
Supplementary Fig. 2C, D, Supplementary Fig. 6C–E are provided as a Source Data file.
One example tomogram as well as our sub-tomogram averages have been deposited in
the EMBD, with the accession code: EMD-10720.
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